Avery Dennison (NYSE:AVY) stock has been under intense scrutiny lately with mixed analyst ratings, despite the firm's strategic movements such as $750M stock buybacks and the CFO returning from medical leave. There has been concern over
Avery Dennison's performance against the Consumer Cyclical Sector and whether it's underperforming both the Dow and the Nasdaq. This is amidst a
52-week low of $172.33 and several firms adjusting their holdings in the AVY stock. It is important to note, those who invested in the company five years ago have seen a
61% growth. While there is investor optimism, critics point towards lack of substantial growth. Despite this, the firm beat Q4 earnings estimates, though their revenues fell short in Q1, and investors fear the stock is not outperforming the broader market. The
intrinsic value of the firm is considered to be potentially 77% above its current share price, signifying a long-term value investment.
Avery Dennison Stocks AVY News Analytics from Fri, 21 Jul 2017 02:14:31 GMT to Wed, 02 Jul 2025 14:47:42 GMT -
Rating -2
- Innovation -3
- Information 2
- Rumor -4
